We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FMFC:NASDAQKandal M Venture Limited Analysis

Data as of 2026-04-04 - not real-time

$0.40

Latest Price

8/10Risk

Risk Level: High

Executive Summary

FMFC is trading at $0.40, well below its 20‑day SMA of $0.46 and 50‑day SMA of $0.41, indicating a bearish price stance. The RSI sits at 45.8, suggesting neutral momentum, while the MACD histogram is negative and the MACD signal is flagged as bearish, reinforcing short‑term downside pressure. Volume trends are decreasing and the stock is hovering just above the identified support level of $0.349, with a sizable resistance near $0.69. Volatility is extreme at 176% over the past 30 days and beta of 1.15 points to heightened sensitivity to market moves, compounded by a historic max drawdown of -98%.
Fundamentally, the company reports negative profit margins (‑1.75%), operating cash flow deficits, and a negative ROE, underscoring ongoing profitability challenges. However, the price‑to‑book (0.92) and price‑to‑sales (0.47) ratios appear cheap, hinting at a potential value opportunity if operational turnaround occurs. Recent news of a new manufacturing facility in the Philippines suggests a strategic effort to diversify production and possibly improve margins, but the impact remains uncertain. Given the lack of dividend, high liquidity risk (low market cap, decreasing volume), and exposure to Cambodian and Philippine regulatory environments, the stock carries a high overall risk profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key SMAs
  • Bearish MACD signal
  • Decreasing volume and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from new Philippines facility
  • Cheap valuation multiples
  • Continued earnings and cash flow deficits

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Significant upside if turnaround succeeds
  • Value-oriented price metrics
  • Strategic diversification of manufacturing footprint

Key Metrics & Analysis

Financial Health

Revenue Growth-17.00%
Profit Margin-1.75%
ROE-6.21%
ROA-2.31%
Debt/Equity1.61
P/B Ratio0.9
Op. Cash Flow$-1916105
Free Cash Flow$-521049

Technical Analysis

TrendNeutral
RSI45.8
Support$0.35
Resistance$0.69
MA 20$0.46
MA 50$0.41
MA 200$4.38
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.15
Volatility176.17%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.